The ISoP Clinical Pharmacometrics Special Interest Group in collaboration with ACCP recently released a white paper highlighting the need for greater exposure-based drug labeling to reduce the widespread and risky practice of off-label dosing. Such a pharmacometric approach to prescribing can improve the care and treatment of individual patients. You can read the whitepaper by clicking…
ISoP’s DE&I Committee is an advisory committee whose role is to provide support within ISoP on DE&I matters in order to ensure that practices and procedures are conducive to proactively fostering a truly inclusive and equitable culture within the organization. Visit the committee page on the ISoP site. (http://go-isop.org/committees/diversity-equity-inclusion-dei-committee/) We would like to hear from…
Are you in the process of searching for a position that fits your professional goals? Are you interested in seeking a promotion within your organization? Are you in need of help to advance your career, but do not know how to build a career advancement plan? If so, then join the ISoP Education Working Group…
To promote the application of pharmacometrics to direct patient care, the International Society of Pharmacometrics (ISOP) and the American College of Clinical Pharmacology are dedicated to fostering an international Special Interest Group of scientists and clinicians who span a wide scope of therapeutic specialties.
The MCS SIG is a forum for ISoP members sharing common interests in advancing mathematical and computational
Welcome to the home of ISoP’s new Special Interest Group (SIG) on Quantitative Systems Pharmocology. This SIG will be a forum for discussion and information sharing between members of ISoP with a interest in systems pharmocology.
The Statistics and Pharmacometrics Interest Group (SxP) was named in 2016 and is chartered by both the American Statistical Association (ASA) and International Society of Pharmacometrics (ISOP). This Interest Group promotes collaboration between Statisticians and Pharmacometricians
